Back to top
more

Fidelity Advisor Biotechnology Cl A: (MF: FBTAX)

(NASDAQ Mutual Funds) As of Feb 20, 2026 05:19 PM ET

$38.36 USD

-0.13 (-0.34%)

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

1-Strong Buy of 5 1        

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Jan 31, 2026

Total Return %* Percentile Rank Objective
YTD 1.39 12
3 months 6.95 57
6 months 36.38 12
1 Year 40.21 10
3 Year 17.73 5
5 Year 7.82 10
10 Year 11.84 8

* Annual for three years and beyond.

Zacks Premium Research for FBTAX

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Strong Buy 1
MF Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

% Unrealized Gain 49.48
% Yield NA
% SEC Yield NA
Net Assets (Mil $) 1/31/2026 772.50
% Turnover 1/31/2026 51.00

Risk

3 Year 5 Year 10 Year
Beta 0.80 0.56 0.76
Alpha 1.41 -0.36 1.01
R Squared 0.21 0.17 0.29
Std. Dev. 20.57 20.32 21.27
Sharpe 0.72 0.32 3.00

Sector / Country Weightings

As of 1/31/2026 % of Portfolio
Health 59.42
Other 24.56
Services 15.71
Finance 0.19
Industrial Cyclical 0.12

Portfolio Holdings

Top Equity Holdings
(As of 10/31/2025)
% of Portfolio Value (Mil$)
ABBVIE INC 16.54 288.66
ALNYLAM PHARMACEUTICALS I 7.64 133.39
GILEAD SCIENCES INC 5.49 95.81
TOTAL*MONEY MARKET 5.34 93.24
ARGENX SE ADR 4.68 81.60
ASCENDIS PHARMA AS ADR 4.28 74.72
INSMED INC 3.92 68.35
UNIQURE NV 2.69 46.93
AMGEN INC 2.58 44.97

Stock Holding % of Net Assets

As Of 10/31/2025
Total Issues 73
Avg. P/E 37.59
Avg. P/Book 5.37
Avg. EPS Growth 15.5
Avg. Market Value (Mil $) 97,879

Composition

% of Portfolio
Stocks 96.93
Foreign Stocks 12.42
Cash 5.34
Bonds 0.00
Foreign Bonds 0.00
Preferred 0.00
Convertible 1.83
Other -4.11
Foreign Hedged 0.00

Style Analysis

% of Portfolio
Large Growth NA
Large Value NA
Small Growth NA
Small Value NA
Foreign Stock NA
Emerging Market NA
Precious Metal NA
Intermediate Bond NA
Foreign Bond NA
High Yield Bond NA